Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2010

Open Access 01-12-2010 | Research

A review of health utilities using the EQ-5D in studies of cardiovascular disease

Authors: Matthew TD Dyer, Kimberley A Goldsmith, Linda S Sharples, Martin J Buxton

Published in: Health and Quality of Life Outcomes | Issue 1/2010

Login to get access

Abstract

Background

The EQ-5D has been extensively used to assess patient utility in trials of new treatments within the cardiovascular field. The aims of this study were to review evidence of the validity and reliability of the EQ-5D, and to summarise utility scores based on the use of the EQ-5D in clinical trials and in studies of patients with cardiovascular disease.

Methods

A structured literature search was conducted using keywords related to cardiovascular disease and EQ-5D. Original research studies of patients with cardiovascular disease that reported EQ-5D results and its measurement properties were included.

Results

Of 147 identified papers, 66 met the selection criteria, with 10 studies reporting evidence on validity or reliability and 60 reporting EQ-5D responses (VAS or self-classification). Mean EQ-5D index-based scores ranged from 0.24 (SD 0.39) to 0.90 (SD 0.16), while VAS scores ranged from 37 (SD 21) to 89 (no SD reported). Stratification of EQ-5D index scores by disease severity revealed that scores decreased from a mean of 0.78 (SD 0.18) to 0.51 (SD 0.21) for mild to severe disease in heart failure patients and from 0.80 (SD 0.05) to 0.45 (SD 0.22) for mild to severe disease in angina patients.

Conclusions

The published evidence generally supports the validity and reliability of the EQ-5D as an outcome measure within the cardiovascular area. This review provides utility estimates across a range of cardiovascular subgroups and treatments that may be useful for future modelling of utilities and QALYs in economic evaluations within the cardiovascular area.
Appendix
Available only for authorised users
Literature
1.
World Health Organisation: The World Health Report 2003: Shaping the Future. Geneva 2003.
2.
Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M: Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006, 27: 1610–1619. 10.1093/eurheartj/ehi733PubMedCrossRef
3.
Swenson JR, Clinch JJ: Assessment of quality of life in patients with cardiac disease - the role of psychosomatic medicine. J Psychosom Res 2000, 48: 405–415. 10.1016/S0022-3999(99)00092-6PubMedCrossRef
4.
The Criteria Committee of the New York Heart Association: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th edition. Boston, Mass.: Little, Brown & Co; 1994.
5.
Campeau L: The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later. Can J Cardiol 2002, 18: 439–442.
6.
Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn SD: Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995, 25: 333–341. 10.1016/0735-1097(94)00397-9PubMedCrossRef
7.
Hofer S, Lim L, Guyatt G, Oldridge N: The MacNew Heart Disease health-related quality of life instrument: A summary. Health Qual Life Outcomes 2004, 2: 3. 10.1186/1477-7525-2-3PubMedCentralPubMedCrossRef
8.
Guyatt G: Measurement of health related quality of life in heart failure. J Am Coll Cardiol 1993,22(Suppl A):185A-191A. 10.1016/0735-1097(93)90488-MPubMedCrossRef
9.
Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002, 21: 271–292. 10.1016/S0167-6296(01)00130-8PubMedCrossRef
10.
Furlong WJ, Feeny DH, Torrance GW, Barr RD: The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001, 33: 375–384. 10.3109/07853890109002092PubMedCrossRef
11.
Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33: 337–343. 10.3109/07853890109002087PubMedCrossRef
12.
Dolan PD: Modelling Valuations for EuroQol Health States. Med Care 1997,35(11):1095–1108. 10.1097/00005650-199711000-00002PubMedCrossRef
13.
Dankova I, Dlouhy M: The measurement of health status with Czech version of European quality of life questionnaire: version EQ-5D. Czech Health Policy Econ 2001, 2.
14.
Wittrup-Jensen K, Lauridsen J, Gudex C, Brooks R, Pedersen K: Estimating Danish EQ-5D tariffs using the time trade-off (TTO) and visual analogue scale (VAS) methods. Lund: Swedish Institute for Health Economics; 257–292.
15.
Lamers L, Stalmeier P, Krabbe P, Busschbach J: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006, 15: 1121–1132. 10.1002/hec.1124PubMedCrossRef
16.
Claes C, Greiner W, Uber A, Schulenberg J-M: The new German version of the EuroQol quality of life questionnaire. Centre for Health Policy and Law, Erasmus University Rotterdam; 1–23.
17.
Shaw JWP, Johnson JAP, Coons SJP: US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model. Med Care 2005, 43: 203–220. 10.1097/00005650-200503000-00003PubMedCrossRef
18.
Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Krabbe P, Ohinmaa A, Parkin D, Roset M, Sintonen H, Tsuchiya A, Charro F: A single European currency for EQ-5D health states. Eur J Health Econ 2003, 4: 222–231. 10.1007/s10198-003-0182-5PubMedCrossRef
19.
WHO: International Statistical Classification of Diseases and Related Health Problems. Geneva 2007.
20.
Higgins J, Thompson SG: Quantifying heterogeneity in meta-analysis. Stat Med 2002, 21: 1539–1558. 10.1002/sim.1186PubMedCrossRef
21.
22.
Nowels D, McGloin J, Westfall JM, Holcomb S: Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Qual Life Res 2005, 14: 95–105. 10.1007/s11136-004-0614-4PubMedCrossRef
23.
Pickard AS, Johnson JA, Feeny DH: Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res 2005, 14: 207–219. 10.1007/s11136-004-3928-3PubMedCrossRef
24.
Spertus J, Peterson E, Conard M, Heidenreich P, Rumholz M, Jones P, McCullogh PA, Pina I, Wooley J, Weintraub WS, Rumsfeld JS: Monitoring clinical changes in patients with heart failure: A comparison of methods. Am Heart J 2005, 150: 707–715. 10.1016/j.ahj.2004.12.010PubMedCrossRef
25.
van Stel H, Buskens E: Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual Life Outcomes 2006, 4: 20. 10.1186/1477-7525-4-20PubMedCentralPubMedCrossRef
26.
Eurich D, Johnson J, Reid K, Spertus J: Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Qual Life Outcomes 2006, 4: 89. 10.1186/1477-7525-4-89PubMedCentralPubMedCrossRef
27.
Dorman P, Slattery J, Farrell B, Dennis M, Sandercock P: Qualitative Comparison of the Reliability of Health Status Assessments With the EuroQol and SF-36 Questionnaires After Stroke. Stroke 1998, 29: 63–68.PubMedCrossRef
28.
Tangelder MJD, McDonnel J, Van Busschbach JJ, Buskens E, Algra A, Lawson JA, Eikelboom BC: Quality of life after infrainguinal bypass grafting surgery. Journal of Vascular Surgery 1999, 29: 913–919. 10.1016/S0741-5214(99)70219-3PubMedCrossRef
29.
Pickard AS, Johnson JA, Feeny DH, Shuaib A, Carriere KC, Nasser AM: Agreement Between Patient and Proxy Assessments of Health-Related Quality of Life After Stroke Using the EQ-5D and Health Utilities Index. Stroke 2004, 35: 607–612. 10.1161/01.STR.0000110984.91157.BDPubMedCrossRef
30.
Hage C, Mattsson E, Stahle A: Long term effects of exercise training on physical activity level and quality of life in elderly coronary patients - A three- to six-year follow-up. Physiother Res Int 2003, 8: 13–22. 10.1002/pri.268PubMedCrossRef
31.
Haacke C, Althaus A, Spottke A, Siebert U, Back T, Dodel R: Long-Term Outcome After Stroke: Evaluating Health-Related Quality of Life Using Utility Measurements. Stroke 2006, 37: 193–198. 10.1161/01.STR.0000196990.69412.fbPubMedCrossRef
32.
Schaaf IC, Wermer MJH, Velthuis BK, Buskens E, Bossuyt PMM, Rinkel GJE: Psychosocial impact of finding small aneurysms that are left untreated in patients previously operated on for ruptured aneurysms. J Neurol Neurosurg Psychiatry 2006, 77: 748–752. 10.1136/jnnp.2005.079194PubMedCentralPubMedCrossRef
33.
Longworth L, Buxton M, Sculpher M, Smith D: Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ 2005, 6: 347–353. 10.1007/s10198-005-0309-yPubMedCrossRef
34.
35.
Borowiak E, Kostka T: Influence of chronic cardiovascular disease and hospitalisation due to this disease on quality of life of community-dwelling elderly. Qual Life Res 2006, 15: 1281–1289. 10.1007/s11136-006-0058-0PubMedCrossRef
36.
Lenzen M, Scholte op Reimer W, Norkvel TM, De Geest S, Fridlund B, Heikkila J, Jaarsma T, Mortensson J, Moons P, Smith K, Stewart S, Stromberg A, Thompson DR, Wijns W: Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization: Results from the Euro Heart Survey on Coronary Revascularization. Eur J Cardiovasc Nurs 2006, 5: 115–121. 10.1016/j.ejcnurse.2006.01.003PubMedCrossRef
37.
Sollano JA, Rose EA, Williams DL, Thornton BM, Quint ER, Apfelbaum MM, Wasserman HM, Cannavale GA, Smith CR, Reemstma KM, Greene RJ: Cost-Effectiveness of Coronary Artery Bypass Surgery in Octogenarians. Annals of Surgery September 1998,228(3):297–306. 10.1097/00000658-199809000-00003CrossRef
38.
Almenar-Pertejo M, Almenar L, Martinez-Dolz L, Campos J, Galan J, Girones P, Ortega F, Ortega T, Rebollo P, Salvador A: Study on Health-Related Quality of Life in Patients With Advanced Heart Failure Before and After Transplantation. Transplant Proc 2006, 38: 2524–2526. 10.1016/j.transproceed.2006.08.017PubMedCrossRef
39.
Austin J, Williams WR, Ross L, Hutchison S: Five-year follow-up findings from a randomized controlled trial of cardiac rehabilitation for heart failure. Eur J Cardiovasc Prev Rehabil 2008, 15: 162–167. 10.1097/HJR.0b013e3282f10e87PubMedCrossRef
40.
Calvert MJ, Freemantle N, Cleland JGF: The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail 2005, 7: 243–251. 10.1016/j.ejheart.2005.01.012PubMedCrossRef
41.
Hofer S, Kullich W, Graninger U, Brandt D, Gassner A, Klicpera M, Laimer H, Marko C, Schwann H, Moller R: Cardiac rehabilitation in Austria: short term quality of life improvements in patients with heart disease. Wien Klin Wochenschr 2006, 118: 744–753. 10.1007/s00508-006-0727-6PubMedCrossRef
42.
Lottman PEM, Laheij RJF, Cuypers PWM, Bender M, Buth J: Health-related quality of life outcomes following elective open or endovascular AAA Repair: A randomised controlled trial. J Endovasc Surg 2004, 11: 323–329.
43.
Sulch D, Melbourn A, Perez I, Kalra L: Integrated Care Pathways and Quality of Life on a Stroke Rehabilitation Unit. Stroke 2002, 33: 1600–1604. 10.1161/01.STR.0000017144.04043.87PubMedCrossRef
44.
Bosch J, Hunink M: Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication. Qual Life Res 2000, 9: 591–601. 10.1023/A:1008929129537PubMedCrossRef
45.
Jowett S, Bryan S, Murray E, McCahon D, Raftery J, Hobbs F, Fitzmaurice D: Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis. Br J Haematol 2006, 134: 632–639. 10.1111/j.1365-2141.2006.06243.xPubMedCrossRef
46.
Granja C, Cabral G, Pinto A, Costa-Pereira A: Quality of life 6-months after cardiac arrest. Resuscitation 2002, 55: 37–44. 10.1016/S0300-9572(02)00203-4PubMedCrossRef
47.
Pickard AS, Wilke CT, Lin HW, Lloyd A: Health Utilities Using the EQ-5D in Studies of Cancer. Pharmacoeconomics 2007, 25: 365–384. 10.2165/00019053-200725050-00002PubMedCrossRef
48.
Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA: Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med 2008, 102: 519–536. 10.1016/j.rmed.2007.11.016PubMedCrossRef
49.
Sullivan PW, Lawrence WF, Ghushchyan VM: A National Catalog of Preference-Based Scores for Chronic Conditions in the United States. Med Care 2005, 43: 736–749. 10.1097/01.mlr.0000172050.67085.4fPubMedCrossRef
50.
Tengs TO, Wallace AM: One Thousand Health-Related Quality-of-Life Estimates. Med Care 2000, 38: 583–637. 10.1097/00005650-200006000-00004PubMedCrossRef
51.
Higgins J, Thompson S, Deeks J, Altman D: Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002, 7: 51–61. 10.1258/1355819021927674PubMedCrossRef
52.
Shrive FM, Ghali WA, Johnson JA, Donaldson CP, Manns BJ: Use of the U.S. and U.K. Scoring Algorithm for the EuroQol-5D in an Economic Evaluation of Cardiac Care. Med Care 2007, 45: 269–273. 10.1097/01.mlr.0000250480.55578.45PubMedCrossRef
53.
Ascione R, Reeves BC, Taylor FC, Seehra HK, Angelini GD: Beating heart against cardioplegic arrest studies (BHACAS 1 and 2): quality of life at mid-term follow-up in two randomised controlled trials. Eur Heart J 2004, 25: 765–770. 10.1016/j.ehj.2003.11.015PubMedCrossRef
54.
Rocca HPB-L, Kaiser C, Bernheim A, Zellweger MJ, Jeger R, Buser PT, Osswald S, Pfisterer M: Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): an 18-month analysis. Lancet 2007, 370: 1552–1559. 10.1016/S0140-6736(07)61660-2CrossRef
55.
Denvir MA, Lee AJ, Rysdale J, Walker A, Eteiba H, Starkey IR, Pell JP: Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention. J Epidemiol Community Health 2006, 60: 1085–1088. 10.1136/jech.2005.044255PubMedCentralPubMedCrossRef
56.
Dunning J, Waller JRL, Smith B, Pitts S, Kendall SWH, Khan K: Coronary Artery Bypass Grafting is Associated With Excellent Long-Term Survival and Quality of Life: A Prospective Cohort Study. Ann Thorac Surg 2008, 85: 1988–1993. 10.1016/j.athoracsur.2008.02.024PubMedCrossRef
57.
Eefting F, Nathoe H, van Dijk D, Jansen E, Lahpor J, Stella P, Suyker W, Diephuis J, Suryapranda H, Ernst S, Borst C, Buskens E, Grobbee D, de Jaegere P: Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty. Circulation 2003, 108: 2870–2876. 10.1161/01.CIR.0000100723.50363.2CPubMedCrossRef
58.
Griffin SC, Barber JA, Manca A, Sculpher MJ, Thompson SG, Buxton MJ, Hemingway H: Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ 2007, 334: 624–628. 10.1136/bmj.39129.442164.55PubMedCentralPubMedCrossRef
59.
Kiessling A, Zethraeus N, Henriksson P: Cost of lipid lowering in patients with coronary artery disease by Case Method Learning. Int J Technol Assess Health Care 2005, 21: 180–186.PubMed
60.
Kim J, Henderson RA, Pocock SJ, Clayton T, Sculpher MJ, Fox KAA: Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: One-year results of the third randomized intervention trial of unstable angina (RITA-3). J Am Coll Cardiol 2005, 45: 221–228. 10.1016/j.jacc.2004.10.034PubMedCrossRef
61.
Kruse M, Hochstrasser S, Zwisler AD, Kjellberg J: Comprehensive cardiac rehabilitation: A cost assessment based on a randomized clinical trial. Int J Technol Assess Health Care 2006, 22: 478–483. 10.1017/S0266462306051403PubMedCrossRef
62.
Lacey EA, Musgrave RJ, Freeman JV, Tod AM, Scott P: Psychological morbidity after myocardial infarction in an area of deprivation in the UK: evaluation of a self-help package. Eur J Cardiovasc Nurs 2004, 3: 219–224. 10.1016/j.ejcnurse.2004.06.005PubMedCrossRef
63.
Legrand VMG, Serruys PW, Unger F, van Hout BA, Vrolix MCM, Fransen GMP, Nielsen TT, Paulsen PK, Gomes RS, de Queiroz de Melo J, Marques dos Santos Neves J, Lindeboom W, Backx B: Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease. Circulation 2004, 109: 1114–1120. 10.1161/01.CIR.0000118504.61212.4BPubMedCrossRef
64.
The Community Pharmacy Medicines Management Project Evaluation Team: The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract 2007, 24: 189–200. 10.1093/fampra/cml075CrossRef
65.
Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, Staples JR, Glas KE, Marshall JJ, Leimbach ME, McCall SA, Petersen RJ, Bailey DE, Weintraub WS, Guyton RA: Off-Pump vs Conventional Coronary Artery Bypass Grafting: Early and 1-Year Graft Patency, Cost, and Quality-of-Life Outcomes: A Randomized Trial. JAMA 2004, 291: 1841–1849. 10.1001/jama.291.15.1841PubMedCrossRef
66.
Reeves BC, Angelini GD, Bryan AJ, Taylor FC, Cripps T, Spyt TJ, Samani NJ, Roberts JA, Jacklin P, Seehra HK, Culliford LA, Keenan DJM, Rowlands DJ, Clarke B, Stanbridge R, Foale R: A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. NCCHTA Health Technol Assess 2004, 8: 1–56.
67.
Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K, Stone D: Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. 11(49). NCCHTA Health Technol Assess 2007, 11: 1–136.
68.
Shrive FM, Manns BJ, Galbraith PD, Knudtson ML, Ghali WA, for The APPROACH Investigators: Economic evaluation of sirolimus-eluting stents. CMAJ 2005, 172: 345–351.PubMedCentralPubMedCrossRef
69.
Taylor RS, Watt A, Dalal HM, Evans PH, Campbell JL, Read KLQ, Mourant AJ, Wingham J, Thompson DR, Pereira Gray DJ: Home-based cardiac rehabilitation versus hospital-based rehabilitation: A cost effectiveness analysis. Int J of Cardiol 2007, 119: 196–201. 10.1016/j.ijcard.2006.07.218CrossRef
70.
Xie J, Wu EQ, Zheng ZJ, Sullivan PW, Zhan L, Labarthe DR: Patient-Reported Health Status in Coronary Heart Disease in the United States: Age, Sex, Racial, and Ethnic Differences. Circulation 2008, 118: 491–497. 10.1161/CIRCULATIONAHA.107.752006PubMedCrossRef
71.
Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L: The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. N Engl J Med 2005, 352: 1539–1549. 10.1056/NEJMoa050496PubMedCrossRef
72.
Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, Lipp A, Daly C, Howe A, Hall R, Harvey I: Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ 2000, 334: 1098. 10.1136/bmj.39164.568183.AECrossRef
73.
Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, Freeman C: Evaluation of the ventricular assist device programme in the UK. NCCHTA Health Technol Assess 2006, 10: 1–138.
74.
Spencer CA, Norman PE, Jamrozik K, Tuohy R, Lawrence-Brown M: Is screening for abdominal aortic aneurysm bad for your health and well-being? ANZ J Surg 2004,74(12):1069–1075. 10.1111/j.1445-1433.2004.03270.xPubMedCrossRef
75.
Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L: A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. NCCHTA Health Technol Assess 2006, 10: 1–132.
76.
Groeneveld P, Matta M, Suh J, Yang F, Shea J: Quality of Life Among Implantable Cardioverter-Defibrillator Recipients in the Primary Prevention Therapeutic Era. Pacing Clin Electrophysiol 2007, 30: 463–471. 10.1111/j.1540-8159.2007.00694.xPubMedCrossRef
77.
van Eck JW, van Hemel NM, van den Bos A, Taks W, Grobbee DE, Moons KG: Predictors of improved quality of life 1 year after pacemaker implantation. Am Heart J 2008, 156: 491–497. 10.1016/j.ahj.2008.04.029PubMedCrossRef
78.
Park J, White AR, James MA, Hemsley AG, Johnson P, Chambers J, Ernst E: Acupuncture for Subacute Stroke Rehabilitation: A Sham-Controlled, Subject- and Assessor-Blind, Randomized Trial. Arch Intern Med 2005, 165: 2026–2031. 10.1001/archinte.165.17.2026PubMedCrossRef
79.
Ryan T, Enderby P, Rigby AS: A randomized controlled trial to evaluate intensity of community-based rehabilitation provision following stroke or hip fracture in old age. Clin Rehabil 2006, 20: 123–131. 10.1191/0269215506cr933oaPubMedCrossRef
80.
Xie J, Wu EQ, Zheng ZJ, Croft JB, Greenlund KJ, Mensah GA, Labarthe DR: Impact of Stroke on Health-Related Qualityof Life in the Noninstitutionalized Population in the United States. Stroke 2006, 37: 2567–2572. 10.1161/01.STR.0000240506.34616.10PubMedCrossRef
81.
Innocenti AD, Elmfeldt D, Hansson L, Breteler M, James O, Lithell H, Olofsson B, Skoog I, Tenkwalder P, Zanchetti A, Wiklund I: Cognitive Function and Health-Related Quality of Life in Elderly Patients with Hypertension - Baseline Data from the Study on COgnition and Prognosis in the Elderly (SCOPE). Volume 11. Blood Press; 2002:157–165.
82.
Krijnen P, van Jaarsveld BC, Hunink MGM, Habbema JDF: The effect of treatment on health-related quality of life in patients with hypertension and renal artery stenosis. J Hum Hypertens 2005, 19: 467–470. 10.1038/sj.jhh.1001847PubMedCrossRef
83.
Lindgren P, Kahan T, Poulter N, Buxton M, Svarvar P, Dahloff B, Jonsson B: Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy. Eur J Health Econ 2007, 8: 25–30. 10.1007/s10198-006-0002-9PubMedCrossRef
84.
Cook TA, Galland RB: Quality of life changes after angioplasty for claudication: medium-term results affected by comorbid conditions. Cardiovasc Surg 1997, 5: 424–426. 10.1016/S0967-2109(97)00037-9PubMedCrossRef
85.
de Vries M, Ouwendijk R, Flobbe K, Nelemans PJ, Kessels AG, Schurink GH, Vliet JA, Heijstraten FMJ, Cuypers JWM, Duijm LEM, van Engelshoven JMA, Hunink MGM, de Haan MW: Peripheral Arterial Disease: Clinical and Cost Comparisons between Duplex US and Contrast-enhanced MR Angiography--A Multicenter Randomized Trial. Radiology 2006, 240: 401–410. 10.1148/radiol.2402050223PubMedCrossRef
86.
Safley DM, House JA, Laster SB, Daniel WC, Spertus JA, Marso SP: Quantifying Improvement in Symptoms, Functioning, and Quality of Life After Peripheral Endovascular Revascularization. Circulation 2007, 115: 569–575. 10.1161/CIRCULATIONAHA.106.643346PubMedCrossRef
87.
Slovacek L, Slovackova B, Chovanec V: The effect of femoral and popliteal percutaneous transluminal balloon angioplasty on patients' quality of life. Sao Paulo Med J 2007, 125: 250–252.PubMedCrossRef
88.
Bosch JL, Graaf Y, Hunink MGM: Health-Related Quality of Life After Angioplasty and Stent Placement in Patients With Iliac Artery Occlusive Disease: Results of a Randomized Controlled Clinical Trial. Circulation 1999, 99: 3155–3160.PubMedCrossRef
89.
Burstrom K, Johannesson M, Diderichsen F: Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001, 10: 621–635. 10.1023/A:1013171831202PubMedCrossRef
90.
Hung HF, Kao PF, Lin YS, Chen FC, Tsai JC, Chan P: Changes of Serum b-Endorphin by Programmed Exercise Training Are Correlated with Improvement of Clinical Symptoms and Quality of Life in Female Mitral Valve Prolapse Syndrome. Cardiology 2007, 108: 252–257. 10.1159/000096952PubMedCrossRef
91.
Maliwa MA, Heijden GJMG, Bots ML, van Hout BA, Casselman FP, van Swieten H, Vermeulen FEE: Quality of life and NYHA class 30 years after mechanical aortic valve replacement. Cardiovasc Surg 2003, 11: 381–387. 10.1016/S0967-2109(03)00030-9PubMedCrossRef
92.
Spiraki C, Kaitelidou D, Papakonstantinou V, Prezerakos P, Maniadakis N: Health-related quality of life measurement in patients with coronary heart disease and heart failure to a cardiology department of a secondary urban hospital in Greece. Hellenic J Cardiol 2008, 49: 241–247.PubMed
93.
van Exel NJA, Scholte op Reimer WJM, Koopmanschap MA: Assessment of post-stroke quality of life in cost-effectiveness studies: The usefulness of the Barthel Index and the EuroQoL-5D. Qual Life Res 2004, 13: 427–433. 10.1023/B:QURE.0000018496.02968.50PubMedCrossRef
94.
de Vries M, Ouwendijk R, Kessels AG, de Haan MW, Flobbe K, Hunink MGM, van Engelshoven JMA, Nelemans PJ: Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg 2005, 41: 261–268. 10.1016/j.jvs.2004.11.022PubMedCrossRef
95.
Busschbach JJV, McDonnell JM, Tangelder MJD, Eikelboom BCM, Buskens EM, Algra AM, Lawson JEM: EuroQol values for economic modelling quality of life after infrainguinal bypass grafting surgery: a rectification. J Vasc Surg 1999, 30: 1162–1163. 10.1016/S0741-5214(99)70058-3PubMedCrossRef
Metadata
Title
A review of health utilities using the EQ-5D in studies of cardiovascular disease
Authors
Matthew TD Dyer
Kimberley A Goldsmith
Linda S Sharples
Martin J Buxton
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2010
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-8-13

Other articles of this Issue 1/2010

Health and Quality of Life Outcomes 1/2010 Go to the issue

Research

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis

Research

Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis

Research

Psychometric properties of the Brief Pain Inventory among patients with osteoarthritis undergoing total hip replacement surgery

Research

Reference bias: presentation of extreme health states prior to eq-vas improves health-related quality of life scores. a randomised cross-over trial

Research

Psychometric properties of the DISABKIDS Chronic Generic Module (DCGM-37) when used in children undergoing treatment for cancer

Research

Quality of life in colon cancer patients with skin side effects: preliminary results from a monocentric cross sectional study